These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 13409061)

  • 41. Hypoglycaemic sulphonamides in the management of diabetes mellitus.
    DOWNIE E; BORNSTEIN J; HUDSON B
    Australas Ann Med; 1957 May; 6(2):105-12. PubMed ID: 13445634
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypoglycaemic sulphonamides in treatment of diabetes.
    WALKER G; LEESE WL; NABARRO JD
    Br Med J; 1956 Aug; 2(4990):451-2. PubMed ID: 13342511
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral insulin substitutes.
    DUNCAN LJ; BAIRD JD
    Scott Med J; 1957 May; 2(5):171-82. PubMed ID: 13432832
    [No Abstract]   [Full Text] [Related]  

  • 44. Observations in diabetic subjects treated with sulfonylurea compounds.
    BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
    Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diabetes chemotherapy].
    SMITH AE
    Praxis; 1956 Oct; 45(43):977-81. PubMed ID: 13389139
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results and clinical aspects of new oral treatment of diabetes mellitus with N-butylsulfanilylurea BZ-55].
    INTROZZI P; MARIGO S
    Minerva Med; 1956 Jun; 47(50):1959-66. PubMed ID: 13348335
    [No Abstract]   [Full Text] [Related]  

  • 47. [Oral therapy of diabetes].
    MELLINGHOFF CH
    Med Klin; 1956 Sep; 51(36):1497-502. PubMed ID: 13358558
    [No Abstract]   [Full Text] [Related]  

  • 48. [Optic nerve disorders during peroral treatment of diabetes].
    PURTSCHER E
    Wien Klin Wochenschr; 1957 May; 69(19):340. PubMed ID: 13456467
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 50. Observations with sulfonylureas in diabetes.
    BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD
    Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055
    [No Abstract]   [Full Text] [Related]  

  • 51. The use of orinase in diabetes.
    BEASER SB
    Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062
    [No Abstract]   [Full Text] [Related]  

  • 52. Trial of an oral hypoglycaemic agent in diabetes.
    WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A
    Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
    [No Abstract]   [Full Text] [Related]  

  • 54. CURRENT investigation of the hypoglycemic action of sulfonylureas.
    Nutr Rev; 1957 May; 15(5):150-1. PubMed ID: 13431090
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hypoglycemic effect of various sulfamides administered orally; treatment of diabetes mellitus with BZ 55].
    SCALABRINO R; PASQUARIELLO G
    Minerva Med; 1956 Jan; 47(9):270-3. PubMed ID: 13309001
    [No Abstract]   [Full Text] [Related]  

  • 57. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 58. Metabolic studies with the arylsulfonylureas.
    KUHL WJ
    Metabolism; 1956 Nov; 5(6 Part 2):953-63. PubMed ID: 13378065
    [No Abstract]   [Full Text] [Related]  

  • 59. ORAL HYPOGLYCEMIC agents.
    Nutr Rev; 1956 Jul; 14(7):203-4. PubMed ID: 13335036
    [No Abstract]   [Full Text] [Related]  

  • 60. [Peroral treatment of diabetes. II. Oral treatment of diabetes mellitus with D 860].
    KUHLMANN F
    Med Klin; 1956 Nov; 51(45):1919-21. PubMed ID: 13386836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.